If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRB..L Regulatory News (RB.)

  • There is currently no data for RB.

Directorate Change

23 Dec 2013 13:04

RECKITT BENCKISER GROUP PLC - Directorate Change

RECKITT BENCKISER GROUP PLC - Directorate Change

PR Newswire

London, December 23

23 December 2013 Reckitt Benckiser Group plc Directorate change: Richard Cousins In accordance with Listing Rule 9.6.11, the Board of Reckitt Benckiser Groupplc (RB) today announces that Richard Cousins, a non-executive director sinceOctober 2009, has decided not to offer himself for re-election as a director ofRB at the AGM to be held in May 2014. Richard is assuming an increasinglyday-to-day operational role as CEO of Compass Group plc which he has concludedwill impact on his ability to devote sufficient time to his role as anon-executive director of RB. He will accordingly retire from the RB Board on 7May 2014. Commenting on today's announcement, Adrian Bellamy, Chairman, said: "The Board thanks Richard for his contribution to the Board since he wasappointed in October 2009 and fully respects and understands his decision tostep down from the RB Board. " For further InformationAndraea Dawson-Shepherd Global Director, Corporate Communication and AffairsTelephone +44 (0) 1753 217 800 Liz Richardson Company SecretaryTelephone +44 (0) 1753 217 800` About Reckitt Benckiser (RB): Reckitt Benckiser (RB) is a global consumer goods leader in health, hygiene andhome. With a purpose of delivering innovative solutions for healthier lives andhappier homes, RB is in the top 25 of companies listed on the London StockExchange. Today it is the global No 1 or No 2 in the majority of itsfast-growing categories, driven by an exceptional rate of innovation. Itshealth, hygiene and home portfolio is led by 19 global Powerbrands includingNurofen, Strepsils Gaviscon, Mucinex, Durex, Scholl, Lysol, Dettol, Clearasil,Veet, Harpic, Bang, Mortein, Finish, Vanish, Woolite, Calgon, Air Wick, andFrench's. RB has close to half of its revenues coming from it 2 emerging marketAreas and just over half from its developed market Area. Over 70% of corerevenues come from the health and hygiene categories of the portfolio. RB people and its culture are at the heart of the company's success. They havean intense drive for achievement and a desire to outperform wherever theyfocus, including in sustainability where the company has reduced its carbonfootprint by 20% in 5 years and is now targeting to deliver a 1/3 reduction inwater impact, 1/3 further reduction in carbon and to have 1/3 of its netrevenue coming from more sustainable products by 2020. It is also the Save theChildren charity's largest FMCG global partner, with a new partnership visionto radically reduce the world's second biggest killer of under fives,diarrhoea. RB has been recognised as a sustainability leader in the CDP Global500 Carbon Performance Leadership Index and received a 2013 Sector MoverSustainability Award in the 10th Sustainability Yearbook. The company has operations in over 60 countries, with headquarters in the UK,Singapore, Dubai and Amsterdam, and sales in almost 200 countries, The companyemploys approximately 36,000 people worldwide.

For more information visit www.rb.com

Date   Source Headline
5th Mar 20194:30 pmRNSDirector Declaration
4th Mar 201911:43 amRNSDirector/PDMR Shareholding
1st Mar 20197:30 amRNSTotal Voting Rights
28th Feb 201911:16 amRNSDirector/PDMR Shareholding
20th Feb 20193:19 pmRNSDirector/PDMR Shareholding
18th Feb 20197:00 amRNSFull Year Results 2018
1st Feb 20198:44 amRNSTotal Voting Rights
16th Jan 20197:05 amRNSRakesh Kapoor to retire as CEO by end of 2019
4th Jan 201911:00 amRNSDirectorate Change
2nd Jan 20192:23 pmRNSDirectorate Change
31st Dec 20181:12 pmRNSTotal Voting Rights
27th Dec 20184:41 pmRNSSecond Price Monitoring Extn
27th Dec 20184:35 pmRNSPrice Monitoring Extension
13th Dec 20189:43 amRNSDirectorate Change
3rd Dec 201810:09 amRNSTotal Voting Rights
19th Nov 201810:11 amRNSDirector Declaration
9th Nov 201811:56 amRNSDirectorate Change
31st Oct 201812:18 pmRNSDirector/PDMR Shareholding
30th Oct 20187:00 amRNSQ3 2018: Trading Update
1st Oct 20185:17 pmRNSDirector/PDMR Shareholding
1st Oct 201812:34 pmRNSTotal Voting Rights
31st Aug 20184:46 pmRNSTotal Voting Rights
31st Aug 20184:00 pmRNSDirectorate Change
8th Aug 20182:32 pmRNSHolding(s) in Company
1st Aug 20189:43 amRNSTotal Voting Rights
27th Jul 20187:00 amRNSHalf Year Results
2nd Jul 201810:01 amRNSTotal Voting Rights
26th Jun 201810:15 amRNSDirectorate Change
7th Jun 20184:55 pmRNSDirector/PDMR Shareholding
1st Jun 201811:28 amRNSTotal Voting Rights
31st May 20184:35 pmRNSPrice Monitoring Extension
29th May 20183:11 pmRNSDirector/PDMR Shareholding
25th May 20185:34 pmRNSDirector/PDMR Shareholding
9th May 20182:00 pmRNSHolding(s) in Company
8th May 20182:00 pmRNSDirector/PDMR Shareholding
4th May 20184:27 pmRNSDirectorate Change
3rd May 20183:17 pmRNSResult of AGM
1st May 20181:00 pmRNSChange in Director's Details
1st May 20189:30 amRNSTotal Voting Rights
20th Apr 20187:00 amRNSQ1 2018 Trading Update
18th Apr 20182:00 pmRNSHolding(s) in Company
3rd Apr 20189:00 amRNSTotal Voting Rights
28th Mar 20185:23 pmRNSAnnual Financial Report
22nd Mar 20187:00 amRNSOffer Talks Terminated
19th Mar 201811:00 amRNSDirectorate Change
1st Mar 201810:59 amRNSTotal Voting Rights
19th Feb 20187:00 amRNSFinal Results
1st Feb 20189:19 amRNSTotal Voting Rights
2nd Jan 201810:07 amRNSTotal Voting Rights
1st Dec 201710:07 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.